Alexion Pharmaceuticals, Inc.

Ownership Transactions Reported by 16 Insiders

Industry
Pharmaceutical Preparations
Location
121 Seaport Boulevard, Boston, Massachusetts

There are no Buy or Sell transactions made by insiders since 7/8/2023

Alexion Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ludwig Hantson CEO, Director $1.61 M Jul 21, 2021
Paul A. Friedman Director Jul 21, 2021
Indrani Franchini EVP, Chief Compliance Officer Jul 21, 2021
Francois Nader Director Jul 21, 2021
Tanisha Carino Evp & Ccao Jul 21, 2021
Brian Goff EVP & Chief Commercial Officer Jul 21, 2021
Christopher J. Coughlin Director Jul 21, 2021
Ellen Chiniara EVP & Chief Legal Officer Jul 21, 2021
Aradhana Sarin Evp, Cfo Jul 21, 2021
Daniel Bazarko SVP, Controller, CAO Jul 21, 2021
Deborah Dunsire Director Jul 21, 2021
John T. Mollen Director Jul 21, 2021
Andreas Rummelt Director Jul 21, 2021
Judith A. Reinsdorf Director Jul 21, 2021
David R. Brennan Director Jul 21, 2021
John Orloff EVP, Research & Development Jul 21, 2021

Recent Insider Transactions by Companies or Individuals for Alexion Pharmaceuticals, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership